SOPHiA GENETICS SA Net Profit Margin 2020-2025 | SOPH
SOPHiA GENETICS SA net profit margin from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| SOPHiA GENETICS SA Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.07B | $-0.07B | -95.59% |
| 2024-12-31 | $0.07B | $-0.06B | -93.94% |
| 2024-09-30 | $0.07B | $-0.07B | -109.23% |
| 2024-06-30 | $0.07B | $-0.07B | -103.08% |
| 2024-03-31 | $0.06B | $-0.07B | -114.06% |
| 2023-12-31 | $0.06B | $-0.08B | -127.42% |
| 2023-09-30 | $0.06B | $-0.07B | -118.97% |
| 2023-06-30 | $0.05B | $-0.08B | -144.44% |
| 2023-03-31 | $0.05B | $-0.08B | -160.78% |
| 2022-12-31 | $0.05B | $-0.09B | -181.25% |
| 2022-09-30 | $0.05B | $-0.09B | -204.35% |
| 2022-06-30 | $0.04B | $-0.09B | -209.09% |
| 2022-03-31 | $0.04B | $-0.09B | -202.38% |
| 2021-12-31 | $0.04B | $-0.07B | -182.50% |
| 2021-09-30 | $0.04B | $-0.06B | -167.57% |
| 2021-06-30 | $0.03B | $-0.05B | -150.00% |
| 2021-03-31 | $0.03B | $-0.04B | -136.67% |
| 2020-12-31 | $0.03B | $-0.04B | -139.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.191B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.172B | 58.74 |
| Hims & Hers Health (HIMS) | United States | $12.418B | 129.02 |
| Tempus AI (TEM) | United States | $12.340B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.751B | 58.61 |
| Privia Health (PRVA) | United States | $2.761B | 188.75 |
| Hinge Health (HNGE) | United States | $2.719B | 0.00 |
| Enovis (ENOV) | United States | $1.822B | 10.16 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Phreesia (PHR) | United States | $1.547B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 65.11 |
| Omnicell (OMCL) | United States | $1.370B | 24.17 |
| 10x Genomics (TXG) | United States | $1.282B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.630B | 0.00 |
| Claritev (CTEV) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 142.50 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.347B | 769.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| Pulmonx (LUNG) | United States | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.095B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |